Low T, ED, weight.Know what worksbefore you pay.

Viagra (sildenafil) remains the clear first-line choice for most men with erectile dysfunction — guideline-endorsed, fast-acting, and backed by decades of randomized trial data.

Tirzepatide produces meaningfully greater fat loss than semaglutide in head-to-head and comparative data — roughly 20% body weight reduction versus 15% at peak doses — and that gap matters for men carrying significant visceral adiposity.

Daily tadalafil at 5 mg produces modestly higher rates of successful intercourse than on-demand dosing and is the only PDE5 inhibitor regimen FDA-approved for both erectile dysfunction and lower urinary tract symptoms from benign prostatic hyperplasia.

Berberine lowers blood sugar — but not like Ozempic does. The honest comparison: berberine is a modest, affordable metabolic adjunct; semaglutide is a potent, FDA-approved drug with proven cardiovascular outcomes.

Stendra (avanafil) wins on speed; Cialis (tadalafil) wins on flexibility and cost. For most men, those two sentences settle the choice — but the details matter enough to read past them.

Brain fog is not listed as an adverse effect in the FDA prescribing information for either Mounjaro or Zepbound — but that doesn't mean patients never experience it.

Tongkat ali (Eurycoma longifolia) produces measurable increases in testosterone and libido in men who start with low or suppressed levels — the evidence for that is solid enough to take seriously.

Retatrutide produces roughly twice the weight loss of Wegovy in clinical trials — approximately 24–29% body weight reduction versus 14.9% for semaglutide 2.4 mg weekly — making it the most potent obesity pharmacotherapy tested in a phase 3 setting to date.

Sildenafil not working doesn't mean you're out of options — it often means you haven't found the right option yet. Research consistently shows that 25–35% of men report inadequate response to Viagra, but a large fraction of those are fixable with better technique, a different…